Back

Directors' Shareholdings

25 January 2008 Deltex Medical Group plc ("Deltex Medical"), the UK's leading haemodynamic monitoring company, today announces that it has today conditionally allotted a total of 413,746 new ordinary shares in the Company to certain non-executive directors of the Company and a former director of the Company at a price of 19.25 pence per share.

The three non-executive directors named below and a former director have elected to take shares in lieu of a cash payment as remuneration for their services to the Company.

The shares will rank pari passu with the existing issued shares of the Company. This allotment is conditional on the appropriate authorities being received at the next general meeting of the Company. Following the issue of these new shares, subject to no changes, the Company will have a total of 92,901,653 ordinary shares in issue.

Following this conditional issue, the directors' beneficial interests will be as follows:

Name of Director		Number of new ordinary shares issued in lieu of fees		Holding of shares following issue of new ordinary shares		% of enlarged issued share capital
Nigel Keen (1)		162,338		4,417,452		4.75
Dr Edwin Snape (2)		116,883		3,373,282		3.63
Andy Hill		-		179,334		0.19
Ewan Phillips		-		977,156		1.05
George Flouty		-		343,984		0.37
Sir Duncan Nichol		91,169		200,130		0.21
Total		370,390		9,491,338		10.21

(1) Includes 589,700 shares held as trustee and executor of Pauline Thomas Charity Will Trust.
(2) Includes shares held as a director of New England Partners and associated companies.

For further information, please contact:

Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman: njk@deltexmedical.com
Andy Hill, Chief Executive: ahill@deltexmedical.com
Ewan Phillips, Finance Director: eap@deltexmedical.com

Charles Stanley Securities 020 7149 6000
Nominated Advisor
Philip Davies: philip.davies@csysecurities.com
Russell Cook: russell.cook@csysecurities.com